Latest Posts
About This Stock
More About This Stock
Read
MediWound Receives Permission To Expand Study Population Scope
![](https://talkmarkets.com/user_content/contacts/thumb_3BDB17B3-7AA3-470A-B59D-745151030921.jpeg?app=199416)
Article By:
KKD Healthcare Analytics
Monday, February 6, 2017 11:21 AM EDT
MediWound announced that it has been granted that it has received an endorsement from The European Medicines Agency for expanding the patient population in Phase 3 Children Innovative Debridement Study.
In this article: MDWD